FDA-approved GLP-1 pill offers cheaper, needle-free option for weight loss
KENT COUNTY, Mich. — A new oral version of the weight loss drug Wegovy has been approved by…
California is ending coverage for weight loss drugs, despite TrumpRx
SACRAMENTO — Many low-income Californians prescribed wildly popular weight-loss drugs will lose their coverage for the medications in the new…
Weight-loss drugs are changing. Here’s what to know about GLP-1s
Weight-loss drugs known as GLP-1s are transforming health care. Some people who struggled for years to shed pounds…
Is Eli Lilly a Millionaire Maker?
Eli Lilly just agreed to lower the price of its blockbuster GLP-1 weight loss drug. More than half…
Doctors warn major changes coming for weight loss drugs in Mass.
Patients and doctors are bracing as some major insurers get ready to roll out changes to coverage for…
2 No-Brainer Healthcare Stocks to Buy Now
Pfizer’s acquisition of obesity drugmaker Metsera positions the pharmaceutical giant to compete in a market expected to reach…
Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma
New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…
Is Eli Lilly a Millionaire Maker?
Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
After Her Unfiltered Body Selfie Went Viral, Amy Schumer Said She’s “Enjoying” How She Looks And Shared More Photos Of Herself Post-Mounjaro
Earlier this year, Amy Schumer opened up about using the drug Mounjaro for weight loss. Gilbert Carrasquillo /…
Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…
Ozempic coming soon to India: What is it? Benefits, side effects and controversies
India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…